Current Italian legislation provides that medical can be administered orally as an extract if it has been titrated to determine the concentration of active molecules. In this context, there is a need to provide known and adequate quantities of active ingredients in order to guarantee uniform therapies that lead to the optimization of risks/benefits. This is fundamental considering that the limited availability on the market of registered -based products for medical use means that prescribed therapies are usually prepared as galenic preparations.
View Article and Find Full Text PDF